Navigating P2Y12 Resistance: Intraoperative Cangrelor Titration During High Risk Vascular Surgery (ASA 2026) - Jul 23, 2026 - Abstract #M2240; Pres time: Oct 18, 2026; 03:30 PM - 03:40 PM; Location: Exhibit Hall; "The patient experienced no major neurologic or bleeding complications. This case highlights the potential role of titratable Cangrelor therapy in DAPT-resistant vascular patients."
Surgery • Cardiovascular • Hematological Disorders • Thrombosis
|
|
Michael Lin, MD1; Mohamed Labib, MD2; Zoe Ozment, MD1.
|